Literature DB >> 19428750

Antigenic differentiation of classical swine fever viruses in China by monoclonal antibodies.

Yan Zhu1, Zixue Shi, Trevor W Drew, Qin Wang, Huaji Qiu, Huanchen Guo, Changchun Tu.   

Abstract

The phylogenetic diversity of classical swine fever virus (CSFV) in China has been extensively studied previously, with the report of the classification of Chinese CSFVs into four subgroups within two of the established genotypes, but the antigenic differences amongst Chinese CSF viruses still remain unknown. To address this issue, 21 CSFV field strains isolated in China between 1996 and 2006 were grown in cell culture and characterized in comparison with two Chinese reference strains: a virulent strain Shimen and a vaccine strain CSF lapinized virus (hog cholera lapinized virus in China, HCLV), by indirect immunofluorescence assay (IFA) with a panel of 28 monoclonal antibodies (mAbs) against four pestiviruses, CSFV, bovine viral diarrhoea virus-1 (BVDV-1), bovine viral diarrhoea virus-2 (BVDV-2) and border disease virus (BDV). All 23 CSFV strains reacted only with CSFV-specific mAbs, not with those raised against BVDV-1, BVDV-2 and BDV. Of the former mAbs, those directed against CSFV E2 protein recognized more isolates than those directed against E(rns) and NS2/3. Of nine CSFV E2-specific mAbs used, WH303 and WH302 reacted with all 23 strains, confirming their value in differentiating CSFV from other pestiviruses. Furthermore, different strains had different patterns of reactivity with CSFV-specific mAbs, and mAbs other than WH303 and WH302 did not recognize all strains. This study provides the first evidence for the existence of antigenic differences among Chinese CSFVs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428750     DOI: 10.1016/j.virusres.2009.02.011

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  7 in total

1.  Characterization of monoclonal antibodies that specifically differentiate field isolates from vaccine strains of classical swine fever virus.

Authors:  Shijiang Mi; Lihua Wang; Hongwei Li; Fei Bao; Rachel Madera; Xiju Shi; Liying Zhang; Yingying Mao; Renhe Yan; Xianzhu Xia; Wenjie Gong; Jishu Shi; Changchun Tu
Journal:  Front Immunol       Date:  2022-07-19       Impact factor: 8.786

2.  Antigenic analysis of classical swine fever virus E2 glycoprotein using pig antibodies identifies residues contributing to antigenic variation of the vaccine C-strain and group 2 strains circulating in China.

Authors:  Ning Chen; Chao Tong; Dejiang Li; Jing Wan; Xuemei Yuan; Xiaoliang Li; Jinrong Peng; Weihuan Fang
Journal:  Virol J       Date:  2010-12-31       Impact factor: 4.099

3.  Challenge of pigs with classical swine fever viruses after C-strain vaccination reveals remarkably rapid protection and insights into early immunity.

Authors:  Simon P Graham; Helen E Everett; Felicity J Haines; Helen L Johns; Olubukola A Sosan; Francisco J Salguero; Derek J Clifford; Falko Steinbach; Trevor W Drew; Helen R Crooke
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

4.  Integrin β3 is required in infection and proliferation of classical swine fever virus.

Authors:  Weiwei Li; Gang Wang; Wulong Liang; Kai Kang; Kangkang Guo; Yanming Zhang
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

5.  In vitro inhibition of CSFV replication by retroviral vector-mediated RNA interference.

Authors:  Jiangnan Li; Huancheng Guo; Zixue Shi; Changchun Tu
Journal:  J Virol Methods       Date:  2010-08-04       Impact factor: 2.014

6.  In vitro inhibition of CSFV replication by multiple siRNA expression.

Authors:  Jiangnan Li; Yajuan Dai; Shuai Liu; Huancheng Guo; Tiedong Wang; Hongsheng Ouyang; Changchun Tu
Journal:  Antiviral Res       Date:  2011-06-14       Impact factor: 5.970

Review 7.  Complex Virus-Host Interactions Involved in the Regulation of Classical Swine Fever Virus Replication: A Minireview.

Authors:  Su Li; Jinghan Wang; Qian Yang; Muhammad Naveed Anwar; Shaoxiong Yu; Hua-Ji Qiu
Journal:  Viruses       Date:  2017-07-05       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.